Tag: biotech
-
Eli Lilly (LLY) Pullback is an Opportunity
Eli Lilly (LLY) is offering opportunity on its recent pullback to $935 a share. After catching support at just under $895, it’s starting to pivot higher again. From here, we’d like to see LLY initially retest $960. Helping, sales of its diabetes and obesity medications, Mounjaro and Zepbound are still strong. Two, LLY yields 0.57%…
-
How to Trade the Biotech M&A Boom
Biotech stocks are breaking higher. All thanks to the return of M&A. Most recently, Bristol Myers agreed to acquire RayzeBio in a $4.1 billion deal, which is a 100% premium to its Friday closing price. “This transaction enhances our increasingly diversified oncology portfolio by bringing a differentiated platform and pipeline, and further strengthens our growth…
-
This Biotech Stock Jumped 1,007% in a Day
Biotech stocks can produce massive wins. Especially if they come up with potential game-changers in health. Look at Ambrx Biopharma (AMAM), for example. On Friday, the stock exploded 1,007% on volume of 123.7 million shares, as compared to the daily average volume of 2.01 million shares. All after the company produced positive results from the…